| 1 |
30675160 | Vanadyl Sulfate Effects on Systemic Profiles of Metabolic Syndrome in Old Rats with Fructose-Induced Obesity. | 2018 |
1 |
| 2 |
24668346 | Structural and redox requirements for the action of anti-diabetic vanadium compounds. | 2014 May 21 |
1 |
| 3 |
12679171 | Effect of chromium on apolipoprotein A-I expression in HepG2 cells. | 2003 Apr |
2 |
| 4 |
12800089 | Vanadate and rapamycin synergistically enhance insulin-stimulated glucose uptake. | 2003 Jun |
1 |
| 5 |
14622970 | Prolongation of insulin-induced activation of mitogen-activated protein kinases ERK 1/2 and phosphatidylinositol 3-kinase by vanadyl sulfate, a protein tyrosine phosphatase inhibitor. | 2003 Dec 1 |
2 |
| 6 |
12500990 | Effect of acute and short-term administration of vanadyl sulphate on insulin sensitivity in healthy active humans. | 2002 Dec |
3 |
| 7 |
11238540 | Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes. | 2001 Mar |
4 |
| 8 |
10520409 | [Insulin resistance: therapeutic approaches]. | 1999 Sep |
1 |
| 9 |
9578588 | Vanadyl sulfate-stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase and is independent of insulin receptor tyrosine phosphorylation. | 1998 May 12 |
2 |
| 10 |
8621019 | Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. | 1996 May |
6 |
| 11 |
7769096 | Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. | 1995 Jun |
1 |